Past Cardiovascular Studies
Metropolitan Clinical Research has successfully conducted patient-focused clinical studies across multiple cardiovascular conditions, helping advance research and support better patient care.
Inflammation Clinical Trials
Coronary artery disease affects the arteries that supply blood to the heart, and inflammation can be part of the disease process. Elevated high-sensitivity C-reactive protein (hsCRP) is a blood marker that can indicate higher levels of inflammation, making it an important area of study in people with coronary artery disease.
Metropolitan Clinical Research conducted a clinical trial in people with coronary artery disease and elevated hsCRP. The study evaluated a potential new treatment that targets a specific pathway involved in inflammation, with a focus on its safety, tolerability, and effects on inflammatory markers.
Current Status:
Our Simple Enrollment Process
From your first conversation to making an informed decision, our experienced research team is here to guide you through each step.
Recruitment & Initial Contact​
Patients learn about the study and connect with the research team.
Pre-Screening
The team asks basic questions to determine whether the patient may meet the study criteria
Informed Consent
Eligible patients review the study details, ask questions, and decide whether to participate.
Connect With Us.
Call us to discuss available clinical studies and your eligibility.